| EPB0217 | The relationship between tenofovir urine and tenofovir diphosphate dried blood spot concentrations among transgender adults switching from tenofovir disoproxil fumarate/emtricitabine to tenofovir alafenamide/emtricitabine for HIV pre-exposure prophylaxis | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0216 | Participant-reported outcomes with long-acting lenacapavir-based regimens among heavily treatment-experienced people living with HIV in the CAPELLA clinical trial | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0215 | Evaluation of clinical outcomes of pregnant women living with HIV receiving prevention of parent to child transmission services in Larkana District Pakistan | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0214 | Evaluation of prevention of parent to child transmission services available for pregnant women living with HIV in Larkana District, Sindh, Pakistan | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0213 | Effects of Atripla® and ethanol co-administration on rat caput epididymis tissues: a study on morphometry and androgen receptor immunoreactivity | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0212 | Implementation of long-acting cabotegravir and rilpivirine in vulnerable populations with complex needs: primary 48-week results of JABS | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0211 | Under-representation of women in HIV clinical trials: how can this still be happening? | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0210 | Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide fixed-dose combination for the treatment of people living with HIV in Argentina: first interim report of the BICTARG cohort | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0209 | Real-world observational study in Europe on the effectiveness and safety of two-drug regimens containing an integrase inhibitor and reverse transcriptase inhibitor (COMBINE-2): week 96 stable switch population results | E-poster | Antiretroviral therapies and clinical issues in adults |
| EPB0208 | Effect on weight changes upon discontinuation of dolutegravir from antiretroviral regimens among persons with HIV who experienced weight gain | E-poster | Antiretroviral therapies and clinical issues in adults |